SEVERANCE AGREEMENTSeverance Agreement • September 26th, 2017 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledSeptember 26th, 2017 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (this “Agreement”) is made and entered into this 25th day of September, 2017 (the “Effective Date”), by and between CTI BioPharma Corp., a Washington corporation (the “Company”), and David Kirske (the “Executive”).